2025 年全球口服藥物傳輸系統市場報告

預計未來幾年口服藥物輸送系統的市場規模將快速成長。到 2029 年，這一數字將成長至 59.7 億美元，複合年成長率為 11.1%。預測期內的成長可歸因於以患者為中心的藥物輸送、老年人口的成長、對標靶治療、生技藥品和胜肽輸送的需求、監管支持和核准以及對研發的投資。預測期內的關鍵趨勢包括患者的便利性和依從性、藥物配方的進步、慢性病的增加、兒科和老年護理以及生物有效性的提高。

預計慢性病發病率的不斷上升將推動未來幾年口服藥物輸送系統市場的成長。慢性病是指持續一年以上的健康狀況，例如癌症、心臟病、中風、糖尿病或關節炎。這些疾病是最常見的慢性疾病，可以控制但無法治愈，需要持續的醫療和營養支持。口服給藥系統為黏膜和粘膜藥物的給藥提供了一種有效、方便的方法，這是許多患有糖尿病和癌症等慢性疾病的患者所需要的。例如，2023年9月，總部設在瑞士的聯合國專門機構世界衛生組織（WHO）報告稱，非傳染性疾病（NCD）或慢性病每年導致4,100萬人死亡，佔死亡總數的74%。其中，心血管疾病導致1,790萬人死亡，癌症造成930萬人死亡，慢性呼吸道疾病導致410萬人死亡，糖尿病導致200萬人死亡。因此，慢性病的日益普及正在推動口服藥物輸送系統市場的成長。

預計未來幾年醫院需求的不斷成長將推動口服藥物輸送系統市場的成長。醫院是為生病或受傷的人提供治療、護理和服務的專門機構。在醫院環境中，口服藥物傳輸系統具有藥物吸收迅速、病患依從性增強、胃腸道副作用減少和藥物釋放控制等優點。例如，2023 年 5 月，代表醫院和醫療保健網路的美國醫療保健貿易組織美國醫院協會 (AHA) 報告稱，醫院總數從 2022 年的 6,093 家增加到 6,129 家。此外，美國所有醫院的住院總數為 34,011,386 人次，高於 2022 年的 33,356,853 人次。因此，醫院不斷成長的需求正在推動口服藥物輸送系統市場的成長。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第 4 章市場：宏觀經濟情景，包括利率、通膨、地緣政治、新冠疫情以及復甦對市場的影響

第5章 全球成長分析與策略分析框架

• 全球口服藥物輸送系統市場的 PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素、限制因素）
• 最終用途產業分析
• 全球口服藥物輸送系統市場：成長率分析
• 全球口服藥物輸送系統市場表現：規模與成長，2019 年至 2024 年
• 全球口服藥物傳遞系統市場預測：規模與成長，2024-2029 年，2034 年
• 口服給藥系統的全球總目標市場 (TAM)

第6章 市場細分

• 全球口服藥物輸送系統市場類型、表現及預測，2019-2024、2024-2029、2034
• 舌下
• 口服錠劑及含片
• 口腔噴霧劑
• 全球口服藥物傳遞系統市場（按應用、性能和預測），2019-2024 年、2024-2029 年、2034 年
• 疼痛管理
• 禁止抽煙
• 心絞痛
• 全球口服藥物輸送系統市場（按最終用戶、績效和預測），2019-2024 年、2024-2029 年、2034 年
• 醫院
• 門診中心
• 其他
• 全球口服給藥系統市場：舌下給藥按類型、性能和預測細分，2019-2024 年、2024-2029 年、2034 年
• 舌下片
• 舌下含片
• 全球口服藥物輸送系統市場：頰錠劑和含片按類型、性能和預測細分，2019-2024 年、2024-2029 年、2034 年
• 頰錠劑
• 口服錠劑
• 全球口服給藥系統市場：口腔噴霧劑按類型、性能和預測細分，2019-2024 年、2024-2029 年、2034 年
• 噴霧液
• 噴霧啫咖哩

第7章 區域和國家分析

• 全球口服藥物輸送系統市場各地區、績效及預測，2019-2024、2024-2029、2034
• 全球口服藥物輸送系統市場（依國家分類）、績效及預測，2019-2024、2024-2029、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第 17 章 德國市場

第 18 章 法國市場

第 19 章：義大利市場

第 20 章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第 25 章：加拿大市場

第26章 南美洲市場

第 27 章：巴西市場

第28章 中東市場

第 29 章：非洲市場

第 30 章競爭格局與公司概況

• 口服藥物輸送系統市場：競爭格局
• 口服藥物輸送系統市場：公司簡介
  • Teva Pharmaceuticals Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Pfizer Incorporated Overview, Products and Services, Strategy and Financial Analysis
  • GlaxoSmithKline Public Limited Company Overview, Products and Services, Strategy and Financial Analysis
  • Indivior PLC Overview, Products and Services, Strategy and Financial Analysis
  • Generex Biotechnology Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

• Catalent Inc.
• Arx Limited Liability Company
• BioDelivery Science International Incorporated
• Cynapsus Therapeutics Incorporated
• Endo Pharmaceuticals Public Limited Company
• Medlab Clinical Ltd.
• AstraZeneca PLC
• F Hoffmann-La Roche Limited
• Dr. Reddy's Laboratories Ltd.
• Takeda Pharmaceutical Company Limited
• Novartis AG
• Novo Nordisk A/S
• Ethypharm SAS
• Applied Pharma Research SA
• Sunovion Pharmaceuticals Inc.

第 32 章 全球市場競爭基準化分析與儀表板

第33章 重大併購

第 34 章 近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

• 2029 年口服藥物輸送系統市場：提供新機會的國家
• 口服藥物輸送系統市場 2029：提供新機會的細分市場
• 口服藥物輸送系統市場 2029：成長策略
  • 基於市場趨勢的策略
  • 競爭對手的策略

第 36 章 附錄

The buccal drug delivery system involves administering the desired medicine through the buccal mucosal membrane lining of the mouth cavity. This method is effective for delivering mucosal and transmucosal drugs. Mucosal drug delivery aims for site-specific drug release on the mucosa, whereas transmucosal permeation entails drug absorption across the mucosal barrier and into the systemic circulation.

The main types of buccal drug delivery systems include sublingual, buccal tablets and lozenges, and oral sprays. The term sublingual refers to the route of administration for systemic medication delivery of buccal drugs. These are applied in various applications such as pain management, smoking cessation, and angina pectoris, and are utilized by hospitals, ambulatory care centers, and other healthcare facilities.

The buccal drug delivery system market research report is one of a series of new reports from The Business Research Company that provides buccal drug delivery system market statistics, including buccal drug delivery system industry global market size, regional shares, competitors with a buccal drug delivery system market share, detailed buccal drug delivery system market segments, market trends and opportunities, and any further data you may need to thrive in the buccal drug delivery system industry. This buccal drug delivery system market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The buccal drug delivery system market size has grown rapidly in recent years. It will grow from $3.55 billion in 2024 to $3.91 billion in 2025 at a compound annual growth rate (CAGR) of 10.3%. The growth in the historic period can be attributed to early drug delivery innovations, pharmaceutical industry adoption, clinical studies and efficacy, market penetration strategies, disease-specific applications.

The buccal drug delivery system market size is expected to see rapid growth in the next few years. It will grow to $5.97 billion in 2029 at a compound annual growth rate (CAGR) of 11.1%. The growth in the forecast period can be attributed to patient-centric drug delivery, rising geriatric population, demand for targeted therapies, biologics and peptides delivery, regulatory support and approvals, investments in r&d. Major trends in the forecast period include patient convenience and compliance, advancements in drug formulations, rise in chronic diseases, pediatric and geriatric care, enhanced bioavailability.

The increasing prevalence of chronic diseases is anticipated to boost the growth of the buccal drug delivery systems market in the future. Chronic diseases are defined as health conditions that last for a year or more, including cancer, heart disease, stroke, diabetes, and arthritis. These illnesses are among the most common chronic conditions that can be managed but not cured, requiring ongoing medical care and nutrition. Buccal drug delivery systems offer an effective and suitable method for administering mucosal and transmucosal drugs needed by many patients suffering from chronic diseases such as diabetes and cancer. For instance, in September 2023, the World Health Organization, a specialized agency of the United Nations based in Switzerland, reported that 41 million deaths, accounting for 74% of global deaths caused by non-communicable diseases (NCDs) or chronic diseases, occur each year. Among these, there were 17.9 million deaths due to cardiovascular diseases, 9.3 million from cancer, 4.1 million from chronic respiratory diseases, and 2.0 million from diabetes. Thus, the increasing prevalence of chronic diseases is driving the growth of the buccal drug delivery systems market.

The rising demand in hospitals is expected to drive the growth of the buccal drug delivery systems market in the future. Hospitals are specialized facilities that provide medical treatment, care, and services to individuals who are ill or injured. In hospital settings, buccal drug delivery systems offer benefits such as rapid drug absorption, enhanced patient compliance, reduced gastrointestinal side effects, and controlled drug release. For example, in May 2023, a report from the American Hospital Association (AHA), a US-based healthcare trade organization representing hospitals and healthcare networks, indicated that the total number of hospitals increased to 6,129, up from 6,093 in 2022. Additionally, total admissions across all U.S. hospitals rose to 34,011,386, compared to 33,356,853 in 2022. Thus, the increasing demand in hospitals is propelling the growth of the buccal drug delivery systems market.

Leading companies in the buccal drug delivery systems market are concentrating on creating innovative solutions, such as oral treatments for plaque psoriasis, to enhance patient outcomes and improve drug delivery efficacy. Oral treatments for plaque psoriasis involve administering medications by mouth to manage and relieve the symptoms of this chronic autoimmune disorder, which is characterized by the rapid proliferation of skin cells resulting in thick, red, scaly patches. For example, in September 2022, Bristol Myers Squibb, a US-based pharmaceutical company, received FDA approval for Sotyktu (deucravacitinib), an oral treatment for adults suffering from moderate-to-severe plaque psoriasis. This approval represents the first new oral therapy for this condition in nearly a decade, introducing a novel mechanism of action as a selective inhibitor of tyrosine kinase 2 (TYK2).

Companies operating in the buccal drug delivery systems market are focusing on product launches to drive revenues. For instance, in February 2023, launch of melatonin oral spray by Arlak Biotech Private Limited. Melatonin oral spray provides an easy and effective way to facilitate the body's natural production of melatonin, aiding in improving sleep quality. This type of product launch addresses specific healthcare needs, contributing to the growth of the buccal drug delivery systems market.

In April 2023, DifGen Pharmaceuticals LLC, a US-based pharmaceutical company, acquired Aveva Drug Delivery Services Inc. This strategic acquisition aimed to enhance DifGen's research and development (R&D) and manufacturing capabilities, ensuring a secure supply of high-quality and cost-effective medications. Aveva Drug Delivery Services Inc. specializes in buccal drug delivery systems, aligning with DifGen's goal of providing advanced and reliable pharmaceutical solutions.

Major companies operating in the buccal drug delivery system market are Teva Pharmaceuticals Industries Ltd., Pfizer Incorporated, GlaxoSmithKline Public Limited Company, Indivior PLC, Generex Biotechnology Corporation, Catalent Inc., Arx Limited Liability Company, BioDelivery Science International Incorporated, Cynapsus Therapeutics Incorporated, Endo Pharmaceuticals Public Limited Company, Medlab Clinical Ltd., AstraZeneca PLC, F Hoffmann-La Roche Limited, Dr. Reddy's Laboratories Ltd., Takeda Pharmaceutical Company Limited, Novartis AG, Novo Nordisk A/S, Ethypharm SAS, Applied Pharma Research SA, Sunovion Pharmaceuticals Inc., Sanofi SA, Bayer AG, Adare Pharmaceuticals Inc., NAPP Pharmaceutical Ltd., Perrigo Company PLC, Reckitt Benckiser Group PLC, Teligent Pharma Inc., Par Pharmaceutical Companies Inc., Acorda Therapeutics Inc., Opiant Pharmaceuticals Inc.

North America was the largest region in the buccal drug delivery systems market share in 2024. The regions covered in the buccal drug delivery system market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the buccal drug delivery system market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The buccal drug delivery system market consists of the sales of drug ingredients such as insulin, nicotine, tizanidine, triptan, nifedipine, flurbiprofen, sodium carboxymethylcellulose, carbopol, glibenclamide, hyaluronic acid, and xanthan gum. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Buccal Drug Delivery System Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on buccal drug delivery system market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for buccal drug delivery system ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The buccal drug delivery system market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Sublingual; Buccal Tablets And Lozenges; Oral Sprays
• 2) By Application: Pain Management; Smoking Cessation; Angina Pectoris
• 3) By End-User: Hospitals; Ambulatory Centers; Other End-Users
• Subsegments:
• 1) By Sublingual: Sublingual Tablets; Sublingual Films
• 2) By Buccal Tablets And Lozenges: Buccal Tablets; Buccal Lozenges
• 3) By Oral Sprays: Spray Solutions; Spray Gels
• Companies Mentioned: Teva Pharmaceuticals Industries Ltd.; Pfizer Incorporated; GlaxoSmithKline Public Limited Company; Indivior PLC; Generex Biotechnology Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Buccal Drug Delivery System Market Characteristics

3. Buccal Drug Delivery System Market Trends And Strategies

4. Buccal Drug Delivery System Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Buccal Drug Delivery System Growth Analysis And Strategic Analysis Framework

• 5.1. Global Buccal Drug Delivery System PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Buccal Drug Delivery System Market Growth Rate Analysis
• 5.4. Global Buccal Drug Delivery System Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Buccal Drug Delivery System Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Buccal Drug Delivery System Total Addressable Market (TAM)

6. Buccal Drug Delivery System Market Segmentation

• 6.1. Global Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Sublingual
• Buccal Tablets And Lozenges
• Oral Sprays
• 6.2. Global Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pain Management
• Smoking Cessation
• Angina Pectoris
• 6.3. Global Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Ambulatory Centers
• Other End-Users
• 6.4. Global Buccal Drug Delivery System Market, Sub-Segmentation Of Sublingual, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Sublingual Tablets
• Sublingual Films
• 6.5. Global Buccal Drug Delivery System Market, Sub-Segmentation Of Buccal Tablets And Lozenges, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Buccal Tablets
• Buccal Lozenges
• 6.6. Global Buccal Drug Delivery System Market, Sub-Segmentation Of Oral Sprays, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Spray Solutions
• Spray Gels

7. Buccal Drug Delivery System Market Regional And Country Analysis

• 7.1. Global Buccal Drug Delivery System Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Buccal Drug Delivery System Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Buccal Drug Delivery System Market

• 8.1. Asia-Pacific Buccal Drug Delivery System Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Buccal Drug Delivery System Market

• 9.1. China Buccal Drug Delivery System Market Overview
• 9.2. China Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Buccal Drug Delivery System Market

• 10.1. India Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Buccal Drug Delivery System Market

• 11.1. Japan Buccal Drug Delivery System Market Overview
• 11.2. Japan Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Buccal Drug Delivery System Market

• 12.1. Australia Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Buccal Drug Delivery System Market

• 13.1. Indonesia Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Buccal Drug Delivery System Market

• 14.1. South Korea Buccal Drug Delivery System Market Overview
• 14.2. South Korea Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Buccal Drug Delivery System Market

• 15.1. Western Europe Buccal Drug Delivery System Market Overview
• 15.2. Western Europe Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Buccal Drug Delivery System Market

• 16.1. UK Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Buccal Drug Delivery System Market

• 17.1. Germany Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Buccal Drug Delivery System Market

• 18.1. France Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Buccal Drug Delivery System Market

• 19.1. Italy Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Buccal Drug Delivery System Market

• 20.1. Spain Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Buccal Drug Delivery System Market

• 21.1. Eastern Europe Buccal Drug Delivery System Market Overview
• 21.2. Eastern Europe Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Buccal Drug Delivery System Market

• 22.1. Russia Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Buccal Drug Delivery System Market

• 23.1. North America Buccal Drug Delivery System Market Overview
• 23.2. North America Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Buccal Drug Delivery System Market

• 24.1. USA Buccal Drug Delivery System Market Overview
• 24.2. USA Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Buccal Drug Delivery System Market

• 25.1. Canada Buccal Drug Delivery System Market Overview
• 25.2. Canada Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Buccal Drug Delivery System Market

• 26.1. South America Buccal Drug Delivery System Market Overview
• 26.2. South America Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Buccal Drug Delivery System Market

• 27.1. Brazil Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Buccal Drug Delivery System Market

• 28.1. Middle East Buccal Drug Delivery System Market Overview
• 28.2. Middle East Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Buccal Drug Delivery System Market

• 29.1. Africa Buccal Drug Delivery System Market Overview
• 29.2. Africa Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Buccal Drug Delivery System Market Competitive Landscape And Company Profiles

• 30.1. Buccal Drug Delivery System Market Competitive Landscape
• 30.2. Buccal Drug Delivery System Market Company Profiles
  • 30.2.1. Teva Pharmaceuticals Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Pfizer Incorporated Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. GlaxoSmithKline Public Limited Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Indivior PLC Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Generex Biotechnology Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Buccal Drug Delivery System Market Other Major And Innovative Companies

• 31.1. Catalent Inc.
• 31.2. Arx Limited Liability Company
• 31.3. BioDelivery Science International Incorporated
• 31.4. Cynapsus Therapeutics Incorporated
• 31.5. Endo Pharmaceuticals Public Limited Company
• 31.6. Medlab Clinical Ltd.
• 31.7. AstraZeneca PLC
• 31.8. F Hoffmann-La Roche Limited
• 31.9. Dr. Reddy's Laboratories Ltd.
• 31.10. Takeda Pharmaceutical Company Limited
• 31.11. Novartis AG
• 31.12. Novo Nordisk A/S
• 31.13. Ethypharm SAS
• 31.14. Applied Pharma Research SA
• 31.15. Sunovion Pharmaceuticals Inc.

32. Global Buccal Drug Delivery System Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Buccal Drug Delivery System Market

34. Recent Developments In The Buccal Drug Delivery System Market

35. Buccal Drug Delivery System Market High Potential Countries, Segments and Strategies

• 35.1 Buccal Drug Delivery System Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Buccal Drug Delivery System Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Buccal Drug Delivery System Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer